1. Home
  2. CHMI vs ARMP Comparison

CHMI vs ARMP Comparison

Compare CHMI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.68

Market Cap

98.5M

Sector

Real Estate

ML Signal

HOLD

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$8.09

Market Cap

383.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
ARMP
Founded
2012
N/A
Country
United States
United States
Employees
14
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
383.7M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CHMI
ARMP
Price
$2.68
$8.09
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.00
$15.00
AVG Volume (30 Days)
148.2K
40.9K
Earning Date
05-05-2026
03-16-2026
Dividend Yield
14.81%
N/A
EPS Growth
N/A
53.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$139.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$0.90
52 Week High
$3.67
$13.75

Technical Indicators

Market Signals
Indicator
CHMI
ARMP
Relative Strength Index (RSI) 53.52 38.43
Support Level $2.68 $5.14
Resistance Level $2.76 $8.17
Average True Range (ATR) 0.07 0.90
MACD 0.00 -0.49
Stochastic Oscillator 64.96 15.42

Price Performance

Historical Comparison
CHMI
ARMP

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: